
|Videos|June 6, 2017 (Updated: December 19, 2020)
Frontline Bostunib vs Imatinib in Chronic Myeloid Leukemia
Author(s)Jorge E. Cortes, MD
This video highlights results of the BFORE trial, which tested bosutinib vs imatinib in newly diagnosed chronic myeloid leukemia patients.
Advertisement
In this video, Jorge E. Cortes, MD, of the University of Texas MD Anderson Cancer Center in Houston, discusses results of the BFORE trial, which tested bosutinib vs imatinib in newly diagnosed chronic myeloid leukemia patients.
Cortes presented the results of the study (
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Iberdomide Combination in R/R Multiple Myeloma
2
Encorafenib/Cetuximab Plus FOLFIRI Improves PFS in BRAF V600E-Mutant mCRC
3
FDA Removes Black Box Warning for Breast Cancer and Other Indications on HRT Products
4
FDA OKs Once-Monthly Subcutaneous Amivantamab Dose in EGFR+ NSCLC
5










































